Horizon Pharma USA, INC

Biopharmaceutical development

Based in IL

🤖

AI Overview

With $210K in lobbying spend across 6 quarterly filings, Horizon Pharma USA, INC is an active lobbying client. Their lobbying covers 2 issue areas.

$210K
Total Spend
1
Years Active
1
Firms Hired
4
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$210K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid

  • Issues related to orphan drugs and the value of innovative medicines.
  • Legislation to address opioids manufacturing and distribution
  • Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA), vaccines and other various provisions.
  • H.R. 4710, 340B PAUSE Act, establishing a moratorium on the registration of new 340B hospitals and associated sites, and requiring reporting of program data.
  • H.R. 1625, Consolidated Appropriations Act

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.